Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1927 | 1 |
| 1929 | 1 |
| 1935 | 1 |
| 1949 | 1 |
| 1950 | 2 |
| 1951 | 1 |
| 1952 | 1 |
| 1953 | 2 |
| 1954 | 3 |
| 1955 | 1 |
| 1956 | 2 |
| 1958 | 2 |
| 1959 | 1 |
| 1960 | 2 |
| 1961 | 4 |
| 1962 | 2 |
| 1963 | 1 |
| 1964 | 6 |
| 1965 | 19 |
| 1966 | 9 |
| 1967 | 12 |
| 1968 | 18 |
| 1969 | 22 |
| 1970 | 19 |
| 1971 | 19 |
| 1972 | 22 |
| 1973 | 21 |
| 1974 | 29 |
| 1975 | 188 |
| 1976 | 149 |
| 1977 | 138 |
| 1978 | 134 |
| 1979 | 127 |
| 1980 | 123 |
| 1981 | 146 |
| 1982 | 151 |
| 1983 | 196 |
| 1984 | 206 |
| 1985 | 225 |
| 1986 | 215 |
| 1987 | 210 |
| 1988 | 191 |
| 1989 | 272 |
| 1990 | 247 |
| 1991 | 262 |
| 1992 | 260 |
| 1993 | 275 |
| 1994 | 271 |
| 1995 | 266 |
| 1996 | 284 |
| 1997 | 296 |
| 1998 | 264 |
| 1999 | 267 |
| 2000 | 290 |
| 2001 | 310 |
| 2002 | 312 |
| 2003 | 309 |
| 2004 | 325 |
| 2005 | 310 |
| 2006 | 339 |
| 2007 | 352 |
| 2008 | 377 |
| 2009 | 369 |
| 2010 | 290 |
| 2011 | 194 |
| 2012 | 246 |
| 2013 | 216 |
| 2014 | 218 |
| 2015 | 185 |
| 2016 | 203 |
| 2017 | 208 |
| 2018 | 203 |
| 2019 | 217 |
| 2020 | 258 |
| 2021 | 254 |
| 2022 | 230 |
| 2023 | 216 |
| 2024 | 162 |
Search Results
11,520 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Current Management of Acute Pulmonary Embolism.
Ann Thorac Cardiovasc Surg. 2020 Apr 20;26(2):65-71. doi: 10.5761/atcs.ra.19-00158. Epub 2019 Oct 5.
Ann Thorac Cardiovasc Surg. 2020.
PMID: 31588070
Free PMC article.
Review.
CONCLUSIONS: Acute PE presents with varying degrees of clinical stability. Patients should be evaluated in the context of various available treatment options including medical, catheter-based, and surgical interventions. SPE is a safe and appropriate treatment optio …
CONCLUSIONS: Acute PE presents with varying degrees of clinical stability. Patients should be evaluated in the context of vari …
Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
Clin Appl Thromb Hemost. 2017 Jul;23(5):410-415. doi: 10.1177/1076029616675970. Epub 2016 Oct 26.
Clin Appl Thromb Hemost. 2017.
PMID: 27789605
Free article.
Review.
Bleeding is the most common complication of all anticoagulants. Any bleeding patient on an anticoagulant should be risk-stratified based on hemodynamic instability, source of bleeding, and degree of blood loss. ...The residual effects of each antico …
Bleeding is the most common complication of all anticoagulants. Any bleeding patient on an anticoagulant should be risk …
Management of Mechanical Prosthetic Heart Valve Thrombosis: JACC Review Topic of the Week.
J Am Coll Cardiol. 2023 May 30;81(21):2115-2127. doi: 10.1016/j.jacc.2023.03.412.
J Am Coll Cardiol. 2023.
PMID: 37225366
Free article.
Review.
Mechanical prosthetic heart valves, though more durable than bioprostheses, are more thrombogenic and require lifelong anticoagulation. Mechanical valve dysfunction can be caused by 4 main phenomena: 1) thrombosis; 2) fibrotic pannus ingrowth; 3) degeneration; and 4) endoc …
Mechanical prosthetic heart valves, though more durable than bioprostheses, are more thrombogenic and require lifelong anticoagulation …
Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency.
Adv Ther. 2023 Oct;40(10):4264-4281. doi: 10.1007/s12325-023-02544-8. Epub 2023 Aug 18.
Adv Ther. 2023.
PMID: 37594666
Free PMC article.
Review.
DOACs, however, are eliminated by the kidneys to varying degrees, and their dosages must be adapted in accordance with renal function. Since creatinine clearance (CrCl) monitoring is recommended in patients with AF receiving DOAC therapy, CrCl must be routinely moni …
DOACs, however, are eliminated by the kidneys to varying degrees, and their dosages must be adapted in accordance with renal function …
Acute Pulmonary Embolism–Its Diagnosis and Treatment From a Multidisciplinary Viewpoint.
Dtsch Arztebl Int. 2021 Sep 17;118(37):618-628. doi: 10.3238/arztebl.m2021.0226. Epub 2021 Sep 17.
Dtsch Arztebl Int. 2021.
PMID: 34857082
Free PMC article.
Review.
The duration of anticoagulation is set according to the risk of recurrence. Systemic thrombolysis is recommended for patients with a high-risk PE, in whom it significantly reduces mortality (odds ratio 0.53, number needed to treat 59). ...CONCLUSION: Newly introduce …
The duration of anticoagulation is set according to the risk of recurrence. Systemic thrombolysis is recommended for patients …
Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
Pharmacotherapy. 2012 Jun;32(6):546-58. doi: 10.1002/j.1875-9114.2011.01049.x. Epub 2012 Apr 24.
Pharmacotherapy. 2012.
PMID: 22531940
Review.
Intravenous unfractionated heparin (UFH) remains an important therapeutic agent, particularly in the inpatient setting, for anticoagulation. Historically, the activated partial thromboplastin time (aPTT) has been the primary laboratory test used to monitor and adjust UFH. …
Intravenous unfractionated heparin (UFH) remains an important therapeutic agent, particularly in the inpatient setting, for anticoagulati …
Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
Ann Pharmacother. 2009 Jun;43(6):1064-83. doi: 10.1345/aph.1L194. Epub 2009 May 19.
Ann Pharmacother. 2009.
PMID: 19458109
Review.
CrCl should be estimated using the Cockcroft-Gault method. Differences are noted in the degree of accumulation of various LMWHs in patients with moderate-to-severe renal impairment, and thus, the degree of dose adjustment may differ among the various LMWHs. . …
CrCl should be estimated using the Cockcroft-Gault method. Differences are noted in the degree of accumulation of various LMWHs in …
Protamine and Heparin Interactions: A Narrative Review.
Ann Card Anaesth. 2024 Jul 1;27(3):202-212. doi: 10.4103/aca.aca_117_23. Epub 2024 Jul 4.
Ann Card Anaesth. 2024.
PMID: 38963354
Free PMC article.
Review.
Protamine has itself dose-dependent anticoagulant properties: It interferes with coagulation factors and platelet function; it stimulates fibrinolysis; it can lead to thrombocytopenia and reduction in thrombin-related platelet aggregation; it decreases platelet response to …
Protamine has itself dose-dependent anticoagulant properties: It interferes with coagulation factors and platelet function; it stimul …
Venous Thromboembolism for the Practicing Cardiologist.
Cardiol Clin. 2021 Nov;39(4):551-566. doi: 10.1016/j.ccl.2021.06.008.
Cardiol Clin. 2021.
PMID: 34686267
Review.
The goal of this review is to ensure that cardiologists are comfortable managing VTE-including risk stratification, anticoagulation therapy, and familiarity with primary reperfusion therapy. Clinical assessment and determination of degree of right ventricular dysfun …
The goal of this review is to ensure that cardiologists are comfortable managing VTE-including risk stratification, anticoagulation t …
The use of direct oral anticoagulants in chronic kidney disease.
Br J Haematol. 2018 Oct;183(2):170-184. doi: 10.1111/bjh.15564. Epub 2018 Sep 5.
Br J Haematol. 2018.
PMID: 30183070
Free article.
Review.
Increasing use of direct oral anticoagulants (DOACs) has made management of non-valvular atrial fibrillation and venous thromboembolism easier in most patients. ...It is hoped that the review will serve as a valuable resource for clinicians involved in anticoagul …
Increasing use of direct oral anticoagulants (DOACs) has made management of non-valvular atrial fibrillation and venous thromboemboli …
Cite